The present invention provides a fused ring compound of the following formula [I] ##STR00001## wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a therapeutic agent for hepatitis C, which contains this compound. The compound of the present invention shows an anti-hepatitis C virus (HCV) action based on the HCV polymerase inhibitory activity, and is useful as a therapeutic agent or prophylactic agent for hepatitis C.

 
Web www.patentalert.com

< Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders

< 3-nitrogen-6, 7-dioxygen steroids and uses related thereto

> Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives

> Methods for using amino acids with affinity for the .alpha.2.delta.-protein
~ 00288